Skip to main content
Clinical Trials/CTRI/2025/07/090230
CTRI/2025/07/090230RecruitingPhase 2/3

Randomized Controlled Clinical Trial Of Munditikadi Churna Along With Guduchi Kwath In Vatarakta

Dr Vishwjeet Vijaykumar Powar1 site in 1 country74 target enrollmentStarted: July 15, 2025Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Recruiting
Sponsor
Enrollment
74
Locations
1
Primary Endpoint
Munditikadi churna along with guduchi kwath in the management

Study Overview

Brief Summary

Vatarakta is a disease related with khavaigunya found in raktavaha strotas which include vitiated vata and rakta, so termed as vatarakta. Due to properties sukshmatva and saratva of vayu, dravatva and saratva of rakta they spread all over body. Vatarakta is a disease of Raktavaha strotas and is a Madhyam margagata vyadhi. (1) Prakupit Vayu along with Raktadushti travels in whole body & affects the joint starting with Parvasandhi especially Padangushta. Vatarakta is described as an independent disease as Vat-Shonita in CharakSamhita, Vagbhat and other samhitas The etiology and symptoms of gout is very much similar to those of vatarakta. Gout is a condition characterized by pathological reaction of joints or particular tissues. Purine is an important byproduct of incomplete protein metabolism, leading into the excess of production of uric acid through their metabolic pathways.The prevalence of Vatrakta is 2.5%.Gout is a chronic inflammatory condition caused by the deposition of MonosodiumUrate (MSU) crystal.It is caused by factors that elevate the concentration of SUA (Serum Uric Acid), leading to hyperuricemia. Continued elevated SUA can result in MSU (Monosodium Urate) crystal deposition in all over body, including joints, soft tissues, cartilage, and organs. The peak age of onset in males is between 40 and 60 years. Hyperurecemia can be defined as the serum uric acid level more than 7 mg/dL in males and 6 mg/dL in females.Classically, gout has been described as occurring in four stages: 1.asymptomatic hyperuricemia, 2.acute gouty arthritis,3. intecritical gout, and 4.advanced or chronic gout

Study Design

Study Type
Interventional
Allocation
Other
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)

Inclusion Criteria

  • 1.Patients would be selected Irrespective of their Gender.
  • 2.Patient presenting with lakshanas of vatrakta like Toda,shoth,daha and Sthabdhata.(10).

Exclusion Criteria

  • Pregnancy and lactating woman.
  • Patient having major systemic illness.

Outcomes

Primary Outcomes

Munditikadi churna along with guduchi kwath in the management

Time Frame: 28 days

Vatarakta.

Time Frame: 28 days

Secondary Outcomes

  • Gud Haritaki along with guduchi kwath in the management(Vatarakta.)

Investigators

Sponsor
Dr Vishwjeet Vijaykumar Powar
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Vishwjeet Vijaykumar Powar

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center

Study Sites (1)

Loading locations...

Similar Trials